FDA Reopens Comments On Drug Ad Rule In New Study's Wake

Law360, New York (January 27, 2012, 5:41 PM EST) -- The U.S. Food and Drug Administration on Friday reopened the comment period for its proposed amendments to its regulations on direct-to-consumer TV and radio ads for prescription drugs, citing the entry of a new consumer perception study into the discussion.

The public will now have until Feb. 27 to weigh in on the impact the recent study could have on the agency's proposed revision of its standards for clear, conspicuous and neutral direct-to-consumer prescription drug advertisements, the FDA announced in a Federal Register notice.

The study...
To view the full article, register now.